WHO vaccine-preventable diseases: monitoring system. 2017 global summary

Last updated 15-July-2017 (data as of 11-July-2017)
Next overall update Fall-2017
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 3'2301 Infant (under 12 months) mortality rate: 442
GDP / capita (US$): 1'8591 Child (under 5 years) mortality rate: 562

Population data in thousands3

  2016  2015  2014  2013  2012  2000  1990  1980 
Total population 114  112  110  109  107  84  72  59 
Births
Surviving infants
Pop. less than 5 years 14  15  15  15  15  12  12 
Pop. less than 15 years 40  39  39  38  38  34  29  23 
Female 15-49 years 30  29  29  29  28  21  18  14 

Number of reported cases

(Click for retrospective incidence data for Kiribati)
Diphtheria
ChartChart
 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  30  170 
Mumps
ChartChart
 
Pertussis
ChartChart
  830  161 
Polio*
ChartChart
 
Rubella
ChartChart
 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Kiribati)
Vaccine year result method % card seen                                                
BCG 2008  89  DHS   22  79  98  72  86  95  80  93  66 
DTP1 2008  82  DHS   22  82  95  83  95  94  95 
DTP3 2008  61  DHS   22  81  87  75  95  94  90  97  43 
DTP4          76  53 
IPV1          81  98 
HepB_BD          79  96  66  84  82  80 
HepB3 2008  61  DHS   22  81  87  75  95  94  90  73 
Hib3 2008  61  DHS   22  81  87  75  95  94 
JapEnc         
MCV1          80  84  91  91  80  75 
MCV2          79  76  84 
MenA         
PCV1          84  97  70  62 
PCV2          82  98  66  72 
PCV3          79  94  57  40 
Pol3 2008  48  DHS   22  82  76  79  91  92  90  97  10 
Rota1          82  98 
RotaC          79  70 
RCV1          80  84  91  91 
TT2plus 2008  44  DHS   22  77  83  99*  50  54 
PAB          80 
VAD1          88  76  99* 
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Kiribati)
BCG
ChartChart
  79  79  72  86  95  80  93  66 
DTP1
ChartChart
  82  81  83  95  94  95  98  68 
DTP3
ChartChart
  81  78  75  95  94  90  97  43 
HepB3
ChartChart
  81  82  75  95  94  90  73 
HepB_BD
ChartChart
  79  75  66  84  82  80 
Hib3
ChartChart
  81  82  75  95  94 
IPV1
  81  52 
MCV1
ChartChart
  80  84  88  91  91  80  75 
MCV2
ChartChart
  79  76  80  84 
PCV3
ChartChart
  79  74  57  40 
Pol3
ChartChart
  82  80  79  91  92  90  97  10 
RCV1
ChartChart
  80  84  88  91  91 
RotaC
ChartChart
  79  37 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90%
From 80 to 89%
From 50 to 79%
Less than 50%
Proportion of districts
not reporting DTP3 coverage
100
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2016 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwP 6 years; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HepB_Pediatric birth; Yes
IPV 14 weeks; Yes
MR 12 months; 6 years; Yes
OPV 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Rotavirus 6, 10 weeks; Yes
Td Yes 5 doses to child bearing aged women and pregnant women

Immunizaton indicators

Indicator Expected answer 2016  2015  2014  2013  2012  2011  2010 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number   2016-2019  2013-2018  2013-2015  2013-2017  2008-2012  2008-2012 
Nº of districts with microplans that include activities to raise immunization coverage number 22   

System performance

Total Nº districts in country number 22 
Nº districts with DTP3 coverage >=80% number   20 
% of districts with DTP3 coverage >=80% From 0 to 100%   91  67  100  100  83  83 
Nº districts with measles (MCV1) coverage >=95% number  
% of districts with MCV1 coverage >=95% From 0 to 100%   32  50  50  17  17 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND   Yes  Yes  Yes  Yes  Yes  Yes 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR   Yes  Yes  Yes  Yes  Yes  Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100%       100    111   

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  Yes  No  No  Yes  Yes 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.